Tofigh Daru Research & Engineering Company
Tofigh Daru Research & Engineering Company, established in 2000, is the R&D center of Tamin Pharmaceutical Investment Company (TPICO) which strategically manages the pharmaceutical companies belonging to Social Security Investment Company in Iran.
At first, TODA (Tofigh Daru) was set up developing new API & Fine chemical projects and executing API plants and successfully accomplished many projects, such as Para-Aminophenol (PAP) in Mashhad, Para-Nitrochlorobenzene (PNCB) in Tabriz, Polyvinylpyrrolidone (PVP) and N-Vinylpyrrolidone (NVP) in Saveh and the Corticosteroids plant in Atra Pharmaceutical Company.
In 2003, TODA started its pharmaceutical peptide project, R&D activities for developing API know-how and Molecular Biology projects, by virtue of having creative experts, experienced scientists and well-equipped facilities.
Based on the scale and scope of development projects with which we are involved, LGM Pharma is able to provide our customers with a seasoned perspective and valuable insight.
One of the main goals of the company is the promotion of the public health by being a leader in the pharma industry as confirmed by obtaining quality-related national and international certificates. Publicizing the company aforementioned certificates is one of the responsibilities of this department.
Various certificates for recognition of the company’s dedication and achievements can be seen in this section.
commercialization of the invention, which could be a novel and innovative method of resolving a problem. This innovative method may result in a totally novel instrument, product or industrial process or could be an improvement in an existing product or process. The company’s patents can be viewed in this section.
Our client base consists of a diverse array of pharmaceutical companies,
as well as academic, contract pharma, private-label and
government organizations from around the world, including:
Herbal pilot plan
Advanced biological products manager